TENAX THERAPEUTICS, INC. Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted
TENAX THERAPEUTICS, INC. (TENX) reported Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted of 5.13 million shares for the 12-month period ending 2021-12-31, per its 10-K filed 2022-03-29.
Discontinued › Notes › Compensation Related Costs › Share-Based Payment Arrangement, Disclosure
us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionEquityInstrumentsGranted · last filed 2022-03-29
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2018-12-31 was 10.48M shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2018-09-30 was 0.00 shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2018-06-30 was 39.83K shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for the quarter ending 2018-03-31 was 46.07K shares, a 78.41% decline year-over-year.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2021 was 5.13M shares, a 54.63% decline from fiscal 2020.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2020 was 11.31M shares.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2018 was 10.57M shares, a 98767.69% increase from fiscal 2017.
- TENAX THERAPEUTICS, INC. share-based compensation arrangement by share-based payment award, non-option equity instruments, granted for fiscal 2017 was 10.69K shares, a 48495.45% increase from fiscal 2016.
| Period end | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 3 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 6 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 8 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 9 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month | Share-based Compensation Arrangement by Share-based Payment Award, Non-Option Equity Instruments, Granted 12 month as first filed |
|---|---|---|---|---|---|---|
| 2021-12-31 | 5.13M shares 10-K · filed 2022-03-29 | |||||
| 2020-12-31 | 11.31M shares 10-K · filed 2022-03-29 | |||||
| 2018-12-31 | 10.48M shares derived: 10-K 12 month − 10-Q 9 month · filed 2020-03-30 | 10.48M shares derived: sum of 2 quarters · filed 2020-03-30 | 10.52M shares derived: sum of 3 quarters · filed 2020-03-30 | 10.57M shares 10-K · filed 2020-03-30 | ||
| 2018-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2018-11-14 | 39.83K shares derived: sum of 2 quarters · filed 2018-11-14 | 85.90K shares 10-Q · filed 2018-11-14 | -116.83K shares derived: sum of 4 quarters · filed 2018-11-14 | ||
| 2018-06-30 | 39.83K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2018-08-14 | 85.90K shares 10-Q · filed 2018-08-14 | -116.83K shares derived: sum of 3 quarters · filed 2018-08-14 | -116.83K shares derived: sum of 4 quarters · filed 2018-08-14 | ||
| 2018-03-31 | 46.07K shares 10-Q · filed 2018-05-15 | -156.66K shares derived: sum of 2 quarters · filed 2018-05-15 | -156.66K shares derived: sum of 3 quarters · filed 2018-05-15 | -156.66K shares derived: sum of 4 quarters · filed 2018-05-15 | ||
| 2017-12-31 | -202.73K shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | -202.73K shares derived: sum of 2 quarters · filed 2018-04-02 | -202.73K shares derived: sum of 3 quarters · filed 2018-04-02 | 10.69K shares 10-K · filed 2018-04-02 | ||
| 2017-09-30 | 0.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2017-11-09 | 0.00 shares derived: sum of 2 quarters · filed 2017-11-09 | 213.42K shares 10-Q · filed 2017-11-09 | 213.01K shares derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2017-06-30 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2017-08-09 | 213.42K shares 10-Q · filed 2017-08-09 | 213.01K shares derived: sum of 3 quarters · filed 2018-04-02 | 213.87K shares derived: sum of 4 quarters · filed 2018-04-02 | ||
| 2017-03-31 | 213.42K shares 10-Q · filed 2017-05-10 | 213.01K shares derived: sum of 2 quarters · filed 2018-04-02 | 213.87K shares derived: sum of 3 quarters · filed 2018-04-02 | |||
| 2016-12-31 | -408.00 shares derived: 10-K 12 month − 10-Q 9 month · filed 2018-04-02 | 452.00 shares derived: sum of 2 quarters · filed 2018-04-02 | 22.00 shares 10-K · filed 2018-04-02 | 430.00 shares 10-K · filed 2017-03-16 | ||
| 2016-09-30 | 860.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2016-11-09 | 430.00 shares 10-Q · filed 2016-11-09 | ||||
| 2016-06-30 | -430.00 shares 10-Q · filed 2016-08-09 | |||||
| 2015-12-31 | 610.00 shares 10-K · filed 2017-03-16 | |||||
| 2015-10-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2015-12-10 | -430.00 shares 10-Q · filed 2015-12-10 | 4.82K shares derived: sum of 3 quarters · filed 2017-03-16 | 4.64K shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-07-31 | -430.00 shares 10-Q · filed 2015-09-09 | 4.82K shares derived: sum of 2 quarters · filed 2017-03-16 | 4.64K shares derived: sum of 3 quarters · filed 2017-03-16 | 4.63K shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2015-04-30 | 5.25K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 5.07K shares derived: sum of 2 quarters · filed 2017-03-16 | 5.06K shares derived: sum of 3 quarters · filed 2017-03-16 | 2.62K shares 10-K · filed 2017-03-16 | -2.62K shares 10-K · filed 2015-07-14 | |
| 2015-01-31 | -180.00 shares derived: 10-Q 9 month − 10-Q 6 month · filed 2015-03-17 | -186.00 shares derived: sum of 2 quarters · filed 2015-03-17 | -2.62K shares 10-Q · filed 2015-03-17 | 268.70K shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-10-31 | -6.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2014-12-15 | -2.44K shares 10-Q · filed 2014-12-15 | 268.88K shares derived: sum of 3 quarters · filed 2017-03-16 | 236.74K shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-07-31 | -2.44K shares 10-Q · filed 2014-09-15 | 268.89K shares derived: sum of 2 quarters · filed 2017-03-16 | 236.74K shares derived: sum of 3 quarters · filed 2017-03-16 | 147.02K shares derived: sum of 4 quarters · filed 2017-03-16 | ||
| 2014-04-30 | 271.32K shares derived: 10-K 12 month − 10-Q 9 month · filed 2017-03-16 | 239.18K shares derived: sum of 2 quarters · filed 2017-03-16 | 149.46K shares derived: sum of 3 quarters · filed 2017-03-16 | 135.66K shares 10-K · filed 2017-03-16 | -135.66K shares 10-K · filed 2014-07-29 | |
| 2014-01-31 | -32.14K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2014-03-17 | -121.87K shares derived: sum of 2 quarters · filed 2014-03-17 | -135.66K shares 10-Q · filed 2014-03-17 | -23.98K shares derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-10-31 | -89.73K shares derived: 10-Q 6 month − 10-Q 3 month · filed 2013-12-17 | -103.52K shares 10-Q · filed 2013-12-17 | 8.16K shares derived: sum of 3 quarters · filed 2016-03-14 | 4.56K shares derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-07-31 | -13.79K shares 10-Q · filed 2013-09-17 | 97.88K shares derived: sum of 2 quarters · filed 2016-03-14 | 94.28K shares derived: sum of 3 quarters · filed 2016-03-14 | 94.28K shares derived: sum of 4 quarters · filed 2016-03-14 | ||
| 2013-04-30 | 111.68K shares derived: 10-KT 12 month − 10-Q 9 month · filed 2016-03-14 | 108.08K shares derived: sum of 2 quarters · filed 2016-03-14 | 108.08K shares derived: sum of 3 quarters · filed 2016-03-14 | 5.32K shares 10-KT · filed 2016-03-14 | -5.32K shares 10-K · filed 2013-06-26 | |
| 2013-01-31 | -3.60K shares derived: 10-Q 9 month − 10-Q 6 month · filed 2013-03-18 | -3.60K shares derived: sum of 2 quarters · filed 2013-03-18 | -106.36K shares 10-Q · filed 2013-03-18 | |||
| 2012-10-31 | 0.00 shares derived: 10-Q 6 month − 10-Q 3 month · filed 2012-12-14 | -102.76K shares 10-Q · filed 2012-12-14 | ||||
| 2012-07-31 | -102.76K shares 10-Q · filed 2012-09-19 | |||||
| 2012-04-30 | -10.47K shares 10-K · filed 2013-06-26 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| PLIANT THERAPEUTICS, INC. (PLRX) | United States | $0.071B | -0.76 |
| PMV Pharmaceuticals, Inc. (PMVP) | United States | $0.071B | -0.95 |
| Yarrow Bioscience, Inc. (YARW) | United States | $0.070B | |
| Lunai Bioworks Inc. (LNAI) | United States | $0.072B | -0.11 |
| Spero Therapeutics, Inc. (SPRO) | United States | $0.073B | 17.41 |
| Connect Biopharma Holdings Ltd (CNTB) | $0.069B | -2.17 | |
| Cingulate Inc. (CING) | United States | $0.073B | -2.64 |
| Aldeyra Therapeutics, Inc. (ALDX) | United States | $0.074B | -5.57 |
| XBiotech Inc. (XBIT) | United States | $0.066B | -1.56 |
| OS Therapies Inc (OSTX) | United States | $0.076B | -2.17 |